The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

CPBayes: Bayesian Meta Analysis for Studying Cross-Phenotype Genetic Associations

A Bayesian meta-analysis method for studying cross-phenotype genetic associations. It uses summary-level data across multiple phenotypes to simultaneously measure the evidence of aggregate-level pleiotropic association and estimate an optimal subset of traits associated with the risk locus. CPBayes is based on a spike and slab prior. The methodology is available from: A Majumdar, T Haldar, S Bhattacharya, JS Witte (2018) <doi:10.1371/journal.pgen.1007139>.

Version: 1.1.0
Depends: R (≥ 3.2.0)
Imports: MASS, stats, forestplot, grDevices, purrr, mvtnorm
Suggests: testthat, knitr, rmarkdown
Published: 2020-12-02
DOI: 10.32614/CRAN.package.CPBayes
Author: Arunabha Majumdar [aut, cre], Tanushree Haldar [aut], John Witte [ctb]
Maintainer: Arunabha Majumdar <statgen.arunabha at gmail.com>
BugReports: https://github.com/ArunabhaCodes/CPBayes/issues
License: GPL-3
URL: https://github.com/ArunabhaCodes/CPBayes
NeedsCompilation: no
Materials: README NEWS
In views: Bayesian, MetaAnalysis
CRAN checks: CPBayes results

Documentation:

Reference manual: CPBayes.pdf
Vignettes: CPBayes (Bayesian meta analysis for studying cross-phenotype genetic associations) package

Downloads:

Package source: CPBayes_1.1.0.tar.gz
Windows binaries: r-devel: CPBayes_1.1.0.zip, r-release: CPBayes_1.1.0.zip, r-oldrel: CPBayes_1.1.0.zip
macOS binaries: r-release (arm64): CPBayes_1.1.0.tgz, r-oldrel (arm64): CPBayes_1.1.0.tgz, r-release (x86_64): CPBayes_1.1.0.tgz, r-oldrel (x86_64): CPBayes_1.1.0.tgz
Old sources: CPBayes archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=CPBayes to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.